Imatinib is a targeted cancer drug (a tyrosine kinase inhibitor) used to treat chronic myeloid leukemia and certain other cancers. The term names the chemical compound and its marketed presentations. In medical literature it appears as a proper noun and is pronounced with emphasis on the second syllable. Overall, it denotes a specific therapeutic agent rather than a common noun.
Full pronunciation guide
